Literature DB >> 32511169

Cognitive Impairment among Veterans in Outpatient Vision Rehabilitation.

Heather E Whitson, Sandra Woolson1, Maren Olsen, Robert Massof2, Stephanie M Ferguson1, Kelly W Muir, John A Dziadul3, Eleanor McConnell, Joan A Stelmack.   

Abstract

SIGNIFICANCE: Outpatient vision rehabilitation improves function in veterans with vision impairment, but the prevalence of cognitive impairment and the degree to which it may affect rehabilitation outcomes in the Veterans Affairs system are unknown.
PURPOSE: The purpose of this study was to determine the prevalence of cognitive impairment among veterans receiving outpatient vision rehabilitation in the Veterans Affairs system and compare the benefits of rehabilitation in veterans with and without cognitive impairment.
METHODS: We conducted cognitive assessments and a nested longitudinal cohort study in veterans with eye disorders at two outpatient rehabilitation sites. Cognition was assessed with the Modified Telephone Interview for Cognitive Status administered in person. Eligible veterans and their companions in the longitudinal study responded to questions about the veteran's function at baseline and 90 days later. Visual function was measured with the 48-item Low Vision Visual Function Questionnaire (LV-VFQ-48) and items from the Activity Inventory.
RESULTS: Of 291 veterans assessed (mean ± standard deviation age, 78.2 ± 12 years), 136 (46.7%) were cognitively intact (Modified Telephone Interview for Cognitive Status scores, ≥33), whereas 58 (19.9%) had borderline scores of 30 to 32, 82 (28.2%) had scores suggesting mild/moderate cognitive impairment (scores of 20 to 29), and 15 (5.2%) had scores suggesting severe cognitive impairment (score of <20). After 90 days, mean LV-VFQ-48 reading scores tended to improve in veterans with (n = 21) and without (n = 28) cognitive impairment. The magnitude of self-reported improvement in LV-VFQ-48 scores was greater among cognitively intact, compared with cognitively impaired, veterans (effect size, 0.56 for reading; 0.71 for visual motor). Veterans and companions reported similar 90-day reduction in difficulty with the veterans' top 3 Activity Inventory goals, regardless of cognitive status.
CONCLUSIONS: Approximately one in three veterans referred to outpatient vision rehabilitation has detectable cognitive impairment, yet many still experience functional improvements. Future research should determine best practices to accommodate challenges associated with cognitive impairment in vision rehabilitation and to track clinically meaningful outcomes.

Entities:  

Mesh:

Year:  2020        PMID: 32511169      PMCID: PMC7291825          DOI: 10.1097/OPX.0000000000001522

Source DB:  PubMed          Journal:  Optom Vis Sci        ISSN: 1040-5488            Impact factor:   2.106


  37 in total

1.  American Geriatrics Society and National Institute on Aging Bench-to-Bedside Conference: Sensory Impairment and Cognitive Decline in Older Adults.

Authors:  Heather E Whitson; Alice Cronin-Golomb; Karen J Cruickshanks; Grover C Gilmore; Cynthia Owsley; Jonathan E Peelle; Gregg Recanzone; Anu Sharma; Bonnielin Swenor; Kristine Yaffe; Frank R Lin
Journal:  J Am Geriatr Soc       Date:  2018-09-24       Impact factor: 5.562

2.  Is early age-related maculopathy related to cognitive function? The Atherosclerosis Risk in Communities Study.

Authors:  Tien Yin Wong; Ronald Klein; F Javier Nieto; Suzana A D Moraes; Thomas H Mosley; David J Couper; Barbara E K Klein; Lori L Boland; Larry D Hubbard; A Richey Sharrett
Journal:  Am J Ophthalmol       Date:  2002-12       Impact factor: 5.258

Review 3.  Recommended stardard procedures for the clinical measurement and specification of visual acuity. Report of working group 39. Committee on vision. Assembly of Behavioral and Social Sciences, National Research Council, National Academy of Sciences, Washington, D.C.

Authors: 
Journal:  Adv Ophthalmol       Date:  1980

4.  Economic Evaluation of Low-Vision Rehabilitation for Veterans With Macular Diseases in the US Department of Veterans Affairs.

Authors:  Kevin T Stroupe; Joan A Stelmack; X Charlene Tang; Yongliang Wei; Scott Sayers; Domenic J Reda; Ellen Kwon; Robert W Massof
Journal:  JAMA Ophthalmol       Date:  2018-05-01       Impact factor: 7.389

5.  Prevalence of cognitive impairment without dementia in the United States.

Authors:  Brenda L Plassman; Kenneth M Langa; Gwenith G Fisher; Steven G Heeringa; David R Weir; Mary Beth Ofstedal; James R Burke; Michael D Hurd; Guy G Potter; Willard L Rodgers; David C Steffens; John J McArdle; Robert J Willis; Robert B Wallace
Journal:  Ann Intern Med       Date:  2008-03-18       Impact factor: 25.391

6.  The health status of elderly veteran enrollees in the Veterans Health Administration.

Authors:  Alfredo J Selim; Dan R Berlowitz; Graeme Fincke; Zhongxiao Cong; William Rogers; Samuel C Haffer; Xinhua S Ren; Austin Lee; Shirley X Qian; Donald R Miller; Avron Spiro; Bernardo J Selim; Lewis E Kazis
Journal:  J Am Geriatr Soc       Date:  2004-08       Impact factor: 5.562

7.  The Activity Inventory: an adaptive visual function questionnaire.

Authors:  Robert W Massof; Lohrasb Ahmadian; Lori L Grover; James T Deremeik; Judith E Goldstein; Carol Rainey; Cathy Epstein; G David Barnett
Journal:  Optom Vis Sci       Date:  2007-08       Impact factor: 1.973

8.  The Veterans Affairs Low Vision Intervention Trial (LOVIT): design and methodology.

Authors:  Joan A Stelmack; X Charlene Tang; Domenic J Reda; D'Anna Moran; Stephen Rinne; Rickilyn M Mancil; Roger Cummings; Gary Mancil; Kevin Stroupe; Nancy Ellis; Robert W Massof
Journal:  Clin Trials       Date:  2007       Impact factor: 2.486

9.  The use of the Modified Telephone Interview for Cognitive Status (TICS-M) in the detection of amnestic mild cognitive impairment.

Authors:  Sarah E Cook; Michael Marsiske; Karin J M McCoy
Journal:  J Geriatr Psychiatry Neurol       Date:  2009-06       Impact factor: 2.680

10.  Outcomes of the Veterans Affairs Low Vision Intervention Trial II (LOVIT II): A Randomized Clinical Trial.

Authors:  Joan A Stelmack; X Charlene Tang; Yongliang Wei; Denise Thomas Wilcox; Timothy Morand; Karen Brahm; Scott Sayers; Robert W Massof
Journal:  JAMA Ophthalmol       Date:  2017-02-01       Impact factor: 7.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.